STERIS plc (NYSE:STE) Declares $0.63 Quarterly Dividend

STERIS plc (NYSE:STE) declared a quarterly dividend on Wednesday, January 28th. Investors of record on Tuesday, February 17th will be given a dividend of 0.63 per share by the medical equipment provider on Thursday, March 19th. This represents a c) dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, February 17th.

STERIS has increased its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 20 years. STERIS has a dividend payout ratio of 22.9% meaning its dividend is sufficiently covered by earnings. Equities analysts expect STERIS to earn $9.93 per share next year, which means the company should continue to be able to cover its $2.52 annual dividend with an expected future payout ratio of 25.4%.

STERIS Trading Down 1.1%

STE traded down $2.85 on Thursday, hitting $258.02. The company had a trading volume of 151,242 shares, compared to its average volume of 452,958. STERIS has a 12-month low of $204.90 and a 12-month high of $269.44. The company has a quick ratio of 1.63, a current ratio of 2.37 and a debt-to-equity ratio of 0.27. The business’s fifty day simple moving average is $259.21 and its 200 day simple moving average is $248.25. The company has a market cap of $25.32 billion, a PE ratio of 37.16 and a beta of 1.03.

STERIS (NYSE:STE) last released its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.09. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. STERIS had a net margin of 12.07% and a return on equity of 14.43%. During the same quarter last year, the business earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Equities research analysts expect that STERIS will post 9.08 EPS for the current year.

Insider Activity at STERIS

In other STERIS news, VP Julia Madsen sold 5,008 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $262.00, for a total value of $1,312,096.00. Following the sale, the vice president owned 10,710 shares in the company, valued at approximately $2,806,020. This represents a 31.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Renato Tamaro sold 5,036 shares of STERIS stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the transaction, the vice president directly owned 5,695 shares of the company’s stock, valued at $1,466,747.25. The trade was a 46.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 25,044 shares of company stock worth $6,586,218. 1.07% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On STERIS

Several large investors have recently bought and sold shares of STE. Norges Bank acquired a new stake in shares of STERIS in the second quarter worth approximately $289,132,000. AQR Capital Management LLC raised its holdings in shares of STERIS by 178.6% during the 3rd quarter. AQR Capital Management LLC now owns 1,183,070 shares of the medical equipment provider’s stock worth $291,704,000 after acquiring an additional 758,423 shares during the period. Boston Partners purchased a new position in STERIS during the third quarter worth about $158,982,000. Orbis Allan Gray Ltd raised its position in shares of STERIS by 36.0% during the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock valued at $504,486,000 after buying an additional 556,088 shares during the period. Finally, Thrivent Financial for Lutherans raised its position in STERIS by 246.4% in the third quarter. Thrivent Financial for Lutherans now owns 553,834 shares of the medical equipment provider’s stock valued at $137,041,000 after purchasing an additional 393,970 shares during the period. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.